ARCHIVES

FDA Approves Generic Oncology Injectable Currently In Shortage

This article is from The Cancer Letter archive.

Vol. 39 No. 36 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

NIH-funded HapMap consortium publishes first phase of catalog.

October 28, 2005

NCI Grants: BSA Subcommittee Recommends Review Of SPORE Program In Year 2000

June 26, 1998

Vasopermeation Technology Awarded Patent For CA Firm.

September 28, 2001

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986

NCAB Committee Close To Definition Of QRA

February 11, 1983